Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Jan 04, 2024 10:19am
57 Views
Post# 35810373

RE:RE:RE:RE:RE:RE:RE:A Mickey Mouse Deal / CoQ10 Deal?

RE:RE:RE:RE:RE:RE:RE:A Mickey Mouse Deal / CoQ10 Deal?"The reason it would achieve a large value even at early stage is that the solution targeted a huge unmet medical need with 28 million patients and no alternative solution its expected to be a multi billion $ drug"

The reason CZO could have a large valuation is that the yeast beta glucan immune booster market is a $1 billion market in the much larger immune booster market and PGX could have the emerging gold standard. The CoQ10 market is also an established market worth $4 billion according to Gilles and CZO has beaten the industry gold standard based on one early test.

The key for CZO is when will the moment of clarity hit the market.

Successful 10X scale-up to 100L this year with industry leader Natex by CZO's side will bring PGX to limited commercial-scale production for the first time. It will put in play decisions concerning mass industrialization of PGX: "
NATEX are experts at design and construction of full-scale commercial plants based on the 100L scale." news release

"This next phase of scale up will allow us to work with commercial partners in nutraceuticals and pharmaceuticals to formulate, test, and commercialize novel products and formulations, including novel functional foods and beverages, novel drugs and various forms of delivery systems,” said Gilles Gagnon, M.Sc., MBA, President and CEO." news release
"Protocol designed for a head-to-head study in animals for testing immune properties of PGX-YBG against a commercial formulation." news release
A licensing deal for PGX for CoQ10 would validate the technology.




<< Previous
Bullboard Posts
Next >>